Sterling Investment Advisors, Ltd.

Position in GILD — Gilead Sciences, Inc.

CIK 1701132 BERWYN, PA

Position in GILD

as of Mar 31, 2026 · filed May 4, 2026 Compact

Position Value

$230,936

+$14,590 QoQ

Shares Held

1,657

-52.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Sterling Investment Advisors, Ltd. holds $17,937,955 across 5 Drug Manufacturers - General names.

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	26,524	$6,736,300
2	AMGN	Amgen Inc	13,184	$4,774,190
3	PFE	Pfizer Inc	143,333	$3,451,458
4	LLY	ELI LILLY & Co	2,444	$2,931,407
5	MDCX	Medicus Pharma Ltd.	100,000	$44,600

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$230,936	1,657	-52.8%	Shares	Sole	2026-05-04
2022-09-30	$216,346	3,507	+0.2%	Shares	Sole	2022-11-03
2022-06-30	$216,335	3,500	-52.7%	Shares	Sole	2022-08-05
2022-03-31	$439,573	7,394	-5.7%	Shares	Sole	2022-05-03
2021-12-31	$569,044	7,837	+0.1%	Shares	Sole	2022-02-02
2021-09-30	$547,065	7,832	+0.1%	Shares	Sole	2021-11-09
2021-06-30	$538,967	7,827	+0.1%	Shares	Sole	2021-07-29
2021-03-31	$505,535	7,822	-20.3%	Shares	Sole	2021-05-04
2020-12-31	$571,880	9,816	-16.5%	Shares	Sole	2021-01-21
2020-09-30	$743,114	11,760	-24.9%	Shares	Sole	2020-10-26
2020-06-30	$1,204,418	15,654	+46.3%	Shares	Sole	2020-07-24
2020-03-31	$799,932	10,700	—	Shares	Sole	2020-04-30
No filing history on record for this holder in this stock.